These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16468149)

  • 1. Does the European pharmaceutical industry have a future?
    McKillop T
    Circulation; 2006 Feb; 113(5):f19-20. PubMed ID: 16468149
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmaceutical industry in the Arab world: challenges, controversies, and future outlook.
    Kandil O
    Drug Discov Today; 2004 Jul; 9(13):543-5. PubMed ID: 15203084
    [No Abstract]   [Full Text] [Related]  

  • 3. The European pharmaceutical outlook.
    Nature; 1993 Feb; 361(6414):765-8. PubMed ID: 8441477
    [No Abstract]   [Full Text] [Related]  

  • 4. An assessment of future training needs for PhD graduates for European pharmaceutical companies: a report from the committee on industrial relations (CIR) of EUFEPS. European Federation for Pharmaceutical Sciences.
    Eur J Pharm Sci; 1999 Feb; 7(3):iii-v. PubMed ID: 10048939
    [No Abstract]   [Full Text] [Related]  

  • 5. What future does the pharmaceutical industry have in the cardiovascular world?
    Braunwald E
    Eur Heart J; 2013 Apr; 34(13):943-4. PubMed ID: 23546415
    [No Abstract]   [Full Text] [Related]  

  • 6. [The common future of urology and the pharmaceutical industry].
    Odenthal G
    Urologe A; 2006 Sep; 45 Suppl 4():41-3. PubMed ID: 16955325
    [No Abstract]   [Full Text] [Related]  

  • 7. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future direction of the molecular modeling industry.
    Richon AB
    Drug Discov Today; 2008 Aug; 13(15-16):665-9. PubMed ID: 18675761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs.
    Timur A; Picone G
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):251-6. PubMed ID: 19527097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006.
    Escaned J; Rydén L; Zamorano JL; Poole-Wilson P; Fuster V; Gitt A; Fernández-Avilés F; Scholte Op Reimer W; de Teresa E; Alonso-Pulpón L; Tendera M;
    Eur Heart J; 2007 Mar; 28(5):634-7. PubMed ID: 17283000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug development. A European-inspired renaissance for China's drug industry?
    Xin H
    Science; 2007 Jul; 317(5837):436-7. PubMed ID: 17656689
    [No Abstract]   [Full Text] [Related]  

  • 12. On macroeconomic characteristics of pharmaceutical generics and the potential for manufacturing and consumption under fuzzy conditions.
    Gascón F; de la Fuente D; Puente J; Lozano J
    Artif Intell Med; 2007 Nov; 41(3):223-35. PubMed ID: 17719212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opinion: the pharmaceutical industry welcomes governor-elect Jim McGreevey.
    Perkins R
    N J Med; 2001 Dec; 98(12):64, 63. PubMed ID: 11778297
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetic technology and the investigative pharmaceutical industry. Prospects for the first decade of a new century].
    Albring M; Czempiel W; Fischer EP
    Med Monatsschr Pharm; 1995 Mar; 18(3):57-67. PubMed ID: 7723708
    [No Abstract]   [Full Text] [Related]  

  • 15. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?
    Preziosi P
    Nat Rev Drug Discov; 2004 Jun; 3(6):521-6. PubMed ID: 15173841
    [No Abstract]   [Full Text] [Related]  

  • 16. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 17. Domestic pharmaceutical production in 1999 reaches yen 6.29 trillion.
    Front Med Biol Eng; 2001; 11(2):153. PubMed ID: 11575465
    [No Abstract]   [Full Text] [Related]  

  • 18. The industry moves confidently into 2006.
    This, the third of a three-part series reporting findings of Medical Device Technology's 2005 European market survey, highlights trends in manufacturing. The conclusions point to a positive coming year for the industry, which is confident in its growth strategy
    Med Device Technol; 2005 Dec; 16(10):34-6. PubMed ID: 16419926
    [No Abstract]   [Full Text] [Related]  

  • 19. Grants will determine European malaria vaccine future.
    Birmingham K; Wunsch H
    Nat Med; 1999 Sep; 5(9):969. PubMed ID: 10470055
    [No Abstract]   [Full Text] [Related]  

  • 20. Next-generation monoclonals less profitable than trailblazers?
    Mitchell P
    Nat Biotechnol; 2005 Aug; 23(8):906. PubMed ID: 16082347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.